Status:
COMPLETED
Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.
Lead Sponsor:
Genzyme, a Sanofi Company
Conditions:
Adhesion Prevention
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will examine the performance of SeprasSpray in patients undergoing abdominal surgery (laparoscopic).
Eligibility Criteria
Inclusion
- Patients 18 years old and over that require laparoscopic abdominal surgery
Exclusion
- Patients who are pregnant or have an ongoing infectious complications from a previous surgery
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00813397
Start Date
September 1 2008
End Date
July 1 2009
Last Update
May 22 2015
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Amiens Nord
Amiens, France, 80054
2
Hopital Avicenne
Bobingy, France, 93009
3
Hopital Beaujon
Clichy, France, 92110
4
Centre Hospitalier Simone Veil
Eaubonne, France, 95602